a.org/","@type":"MusicRecording","@id":"https://play.anghami.com/song/1202710351","url":"https://play.anghami.com/song/1202710351","name":"John Chia on the ASCOLT trial of adjuvant aspirin for colorectal cancer","description":"The Lancet Gastroenterology & Hepatology in conversation with · Episode · 2025","datePublished":"2025-03-06","image":"https://artwork.anghcdn.co/webp/?id=200557229&size=640","byArtist":{"@type":"MusicGroup","name":"The Lancet Group"},"inAlbum":{"@type":"MusicAlbum","name":"The Lancet Gastroenterology & Hepatology in conversation with"},"potentialAction":{"@type":"ListenAction","target":[{"@type":"EntryPoint","urlTemplate":"https://play.anghami.com/song/1202710351?autoplay=true","actionPlatform":["http://schema.org/DesktopWebPlatform","http://schema.org/IOSPlatform","http://schema.googleapis.com/GoogleAudioCast","http://schema.googleapis.com/GoogleVideoCast"]},"android-app://com.anghami/song/ 1202710351?autoplay=true"],"expectsAcceptanceOf":{"@type":"Offer","category":"free"}}}1c:T440,

John Chia discusses the results of the ASCOLT trial, which explored the effect of aspirin after completion of standard adjuvant therapy for patients with colorectal cancer.

Read the full article:

https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00387-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas

Continue this conversation on social!

https://bsky.app/profile/lancetgastrohep.bsky.social

https://www.linkedin.com/company/langastro/

https://instagram.com/thelancetgroup

https://facebook.com/thelancetmedicaljournal

John Chia on the ASCOLT trial of adjuvan...